Scientists develop novel vaccine for Lassa fever and rabies
A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.
Search Results: “Hemorrhagic Fever Viruses”
Golden syrian hamster in a tube
Golden Syrian hamsters are susceptible to a virus called SV40 which is related to human-associated viruses in a family called polyomaviruses. SV40 is a virus that causes cancer in hamsters making them a valuable model for studying how these types of viruses may cause cancer in humans in…
Ebola vaccine inches toward human clinical trials
A whole-virus vaccine to confront Ebola, the rare but often fatal hemorrhagic disease that periodically erupts in sub-Saharan Africa, may soon be one step closer to the clinic.
Love, Care, Progress: Inside a Nonhuman Primate Research Facility
Love, Care, Progress: Inside a Nonhuman Primate Research Facility highlights the critically important role of nonhuman primates in health research. This moving story is meant to serve as a conversation starter about the irreplaceable benefits of animal studies and the high standards of care these amazing creatures receive.…
Monkey Eating Oranges
Credit: Photo by Clem Spalding, Courtesy of Texas Biomedical Research Institute
OHSU doc dreams of lifetime immunity with one flu shot
“You don’t really know fear until your kids get sick and you think something’s terribly wrong,”
AIDS vaccine using engineered herpes virus works in monkeys
Rhesus macaques have long been considered the prime model for AIDS vaccine research – as well as for understanding a host of other global infectious viruses such as Ebola, Zika, Dengue and malaria – because these monkeys’ immune systems are analogous to humans.
NIH-supported scientists reverse HIV and SIV latency in two animal models
Findings represent progress toward an HIV cure.
To tackle the new coronavirus, scientists are accelerating the vaccine process
Researchers are turning to nontraditional approaches to create vaccines and therapeutics